Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FF/VI vs VI on Bone Mineral Density in COPD
NCT01957150Phase 4Completed
- Sponsor
- GSK
- Start
- Jan 2014
- Primary completion
- Mar 2018
- Modality
- Orthosteric Ligands
- Countries
- 5
01
Overview
A Phase 4 trial of fluticasone in chronic obstructive pulmonary disease (COPD), sponsored by GSK. Started Jan 2014; status: completed.
02
Drugs
fluticasone
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT01957150.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01957150.